Most Recent
Class actions brought by victims of the failed Willmott Forests managed investment scheme have come to a close, two years after a judge issued a stunning ruling rejecting an initial settlement as favoring clients of M&K Lawyers over other investors, and including payment of a hefty legal bill.
The judge overseeing a case brought by Meat & Livestock Australia over a bovine gene patent has given parties until July 5 to oppose changes to the patent, held by Cargill and Branhaven, after an earlier ruling invalidated the patent.
Boutique law firm Phi Finney McDonald has been chosen among three competing cases to lead a shareholder class action against GetSwift.
Telecom giant Optus has been ordered to pay a $1.5 million penalty for misleading customers about the transition to the National Broadband Network.
The Registered Organisations Commissioner has filed Federal Court proceedings against the Australian Workers' Union, alleging the union broke the law by failing to keep an accurate register of its members.
A decision on the fate of three class actions against logistics software company GetSwift is set for Wednesday, and counsel behind the competing cases aren't the only lawyers waiting with baited breath.
China-based food retailer Winha Commerce has secured an interim court injunction barring the Australian Stock Exchange from delisting the company after the exchange issued queries to all Chinese listed companies about problems converting the renminbi.
A judge overseeing a trial against S&P Global over its ratings of synthetic collateralised debt obligations has tossed the company's damages expert, saying she lacked sufficient expertise to provide an opinion on the value of the instruments.
The ACCC will face a test of its ability to win misuse of market power cases when a long-awaited judgment is handed down this week in the regulator's appeal of a ruling dismissing its case alleging Pfizer misused its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.
Just two months after the retailer announced it would close down all of its US and UK stores, the Australian unit of Toys 'R' Us has announced it has gone into voluntary administration.